A Single-center, Prospective, Cohort Study of the Safety and Efficacy of Single Antiplatelet Therapy After Pipeline Flex with Shield Stent Implantation for Intracranial Aneurysms
The objective of this study was to evaluate the safety and efficacy of single antiplatelet therapy after Pipeline flex with Shield stent implantation for intracranial aneurysms.
⁃ Patients with unruptured intracranial aneurysms who received the intracranial Pipeline Flex with Shield stent.
⁃ Vascular conditions:
‣ 1\) There was no obvious calcification and stenosis of the parent artery. 2) The curvature of the bearing artery is minimal. 3) The parent artery diameter ≥2.5mm
• According to the committee's assessment, only one Pipeline flex with shield is needed for aneurysm treatment.
• Before the stent implantation procedure, standard dual antiplatelet therapy should be administered for at least 3 days.
• Patients with an Modified Rankin Scale(mRS) score of less than 2 on the day of registration.
• The operation was successful, and immediate postoperative angiography indicated good wall apposition.